HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xianghong Zhao Selected Research

Adenosine (Adenocard)

1/2022Adenosinergic axis and immune checkpoint combination therapy in tumor: A new perspective for immunotherapy strategy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xianghong Zhao Research Topics

Disease

4Neoplasms (Cancer)
04/2024 - 01/2022
4Multiple Myeloma
02/2024 - 10/2023
2Breast Neoplasms (Breast Cancer)
04/2024 - 06/2023
1Triple Negative Breast Neoplasms
04/2024
1Immune System Diseases (Immune Disorders)
11/2023
1Inflammation (Inflammations)
01/2021
1Stroke (Strokes)
01/2021
1Ischemic Stroke
01/2021

Drug/Important Bio-Agent (IBA)

2human ERBB2 proteinIBA
04/2024 - 06/2023
2Immune Checkpoint InhibitorsIBA
04/2024 - 11/2023
1Bortezomib (Velcade)FDA Link
02/2024
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
06/2023
1Biomarkers (Surrogate Marker)IBA
01/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1CytokinesIBA
01/2022
1ChemokinesIBA
01/2022
1Adenosine (Adenocard)FDA LinkGeneric
01/2022
1CTLA-4 AntigenIBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2021
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2021

Therapy/Procedure

4Therapeutics
04/2024 - 01/2022
3Immunotherapy
01/2024 - 01/2022
1Drug Therapy (Chemotherapy)
04/2024